-
Dutasteride and the Next Era of Prostate Translation
2026-09-28
Dutasteride offers a powerful framework for connecting androgen metabolism, prostate cancer phenotypes, and translational study design while highlighting the limits of cell-autonomous models.
-
JC-1 Mitochondrial Membrane Potential Assay in Cancer
2026-09-28
Pair the JC-1 Mitochondrial Membrane Potential Assay Kit with carefully matched controls to test whether cancer treatments alter mitochondrial polarization—not simply whether cells are dying. The workflow is especially useful as a follow-up readout in hypoxia-activated phototherapy studies, where oxygen, light exposure, and treatment effects must be separated.
-
Capsaicin Workflows for TRPV1, Itch, and KDM1A
2026-09-27
Capsaicin is a practical probe for studying TRPV1-dependent sensory responses and, separately, KDM1A-associated cancer biology. This guide turns chronic-dermatitis findings into assay choices, controls, and troubleshooting steps while distinguishing published observations from workflow starting points.
-
E-4031 in 3D Cardiac Electrophysiology
2026-09-26
Explore how the hERG potassium channel blocker E-4031 can help interrogate repolarization and arrhythmia-like behavior in cardiac organoids. A practical, evidence-grounded guide explains what 3D shell MEA mapping adds—and what its signals can and cannot establish.
-
Amitriptyline HCl (B2231): Practical Assay Guide
2026-09-25
Amitriptyline HCl (SKU B2231) provides a characterized small molecule for investigating neurotransmitter receptor modulation in neuropharmacology research. Use the dossier values to plan assay setup and handling, but do not treat them as a universal dose, proof of a disease mechanism, or evidence of therapeutic efficacy.
-
SU5416: Linking VEGFR2 Biology to Vascular Context
2026-09-25
SU5416 (Semaxanib) offers a way to interrogate VEGFR2-dependent angiogenesis, but translational interpretation depends on the wider vascular state. This article connects receptor inhibition with emerging evidence on normoxic HIF1α signaling and offers practical guidance for designing and interpreting experiments.
-
Defactinib: A FAK Phosphorylation Workflow
2026-09-24
Use Defactinib to test whether FAK Tyr397 signaling contributes to cancer-cell growth or paclitaxel response, with target engagement measured alongside functional outcomes. A practical workflow combines phosphoprotein controls, dose-response design, and careful interpretation of combination effects—without confusing assay principles with evidence from unrelated disease models.
-
3D Cardiac Organoid Mapping with Shell Microelectrode Arrays
2026-09-24
The study introduces shape-adaptive shell microelectrode arrays that record cardiac organoid activity across a three-dimensional surface, addressing the planar sampling limits of conventional MEAs. By combining spatial electrophysiology with calcium imaging and pharmacological challenges, the platform supports more detailed analysis of conduction patterns and drug responses in organoid models.
-
Cabozantinib: Reading Acute and Chronic RCC Responses
2026-09-24
Cabozantinib (XL184) can produce different signaling and motility readouts depending on exposure history. This article turns recent RCC phosphoproteomic findings into a practical framework for choosing assays and interpreting chronic-treatment adaptation without mistaking it for target reactivation.
-
Separating Growth Inhibition from Cancer Cell Killing
2026-09-23
Hannah R. Schwartz’s dissertation identifies a major interpretive problem in anticancer drug testing: relative viability and fractional viability are often treated as equivalent even though they capture different biological outcomes. The work provides a framework for separating proliferative arrest from actual cell death, improving concentration–time interpretation and the design of mechanistic validation experiments.
-
PLGA Microspheres for Controlled Cartilage Delivery
2026-09-22
A 2026 Pharmaceutics study shows that PLGA microsphere size, surface chemistry, and corticosteroid stability jointly determine transport through articular cartilage. Its combination of emulsion fabrication, bovine explant testing, bi-exponential modeling, and HPLC-based hydrolysis analysis provides a practical framework for designing more predictable intra-articular delivery systems.
-
EHEC Prevents Precocious Puberty in Danazol Models
2026-09-22
A 2025 study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty induced by Danazol or a high-fat diet. The intervention delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA without changing body weight, supporting further investigation of central hypothalamic–pituitary–gonadal axis modulation.
-
Calnexin-Dependent Rescue of Clinical CFTR Variants
2026-09-21
The 2025 eLife study used deep mutational scanning to define how calnexin shapes expression and corrector response across 232 clinical CFTR variants. Its findings show that proteostasis context is a major determinant of variant-specific rescue, helping separate trafficking correction from CFTR channel function in cystic fibrosis research.
-
DAPI Nuclear Stain Solution: Protocol Guide
2026-09-21
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution K2402 provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint cell viability assessment. It is best suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
Vernakalant Hydrochloride Research Workflows
2026-09-20
Vernakalant Hydrochloride enables mechanism-led studies of atrial-selective electrophysiology, from ion-channel assays to PK/PD translation. This workflow connects RSD1235 exposure, CYP2D6 metabolism, and functional readouts while highlighting practical troubleshooting for reproducible experiments.